XIG: FHIR Resources

FHIR IG Statistics: FHIR Resources

Version: All | R2 | R2B | R3 | R4 | R4B | R5 | R6
Authority: All | hl7 | ihe | national
Realm: All | BNW | au | be | br | ca | ch | cl | cr | cz | de | dk | ee | eu | fi | fr | il | in | it | jp | nl | no | nz | pt | se | sl | stt | tw | uk | us | uv | vn
View: All | Resource Profiles | Datatype Profiles | Extensions | Logical Models | CodeSystems | ValueSets | ConceptMaps

Resources - All Kinds, Realm US, Authority Hl7

16,284 resources

By Version

R2: 52
R2B: 0
R3: 523
R4: 15,269
R4B: 0
R5: 440
R6: 0

Start Prev Rows 10800 - 11000 Next

Package	Version	Identity	Name/Title	Status	Date
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.101.12.1087	Outpatient Encounter	active	2025-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.101.12.1088	Frailty Encounter	active	2021-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.101.12.1090	Palliative Care Encounter	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1010	Multiple Myeloma	active	2021-08
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1011	Multiple Myeloma	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1012	Premature Menopause	active	2021-08
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1013	Premature Menopause	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1014	Multiple Myeloma	active	2022-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1015	Premature Menopause	active	2022-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1019	Amenorrhea	active	2021-09
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.102.11.1031	Acute Pharyngitis	active	2017-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.102.11.1033	Acute Pharyngitis	active	2017-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.102.11.1034	Acute Tonsillitis	active	2019-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.102.11.1036	Acute Tonsillitis	active	2017-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.102.11.1058	Upper Respiratory Infection	active	2017-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.102.11.1059	Upper Respiratory Infection	active	2023-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.102.11.1066	Comorbid Conditions for Respiratory Conditions	active	2022-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.102.11.1067	Comorbid Conditions for Respiratory Conditions	active	2021-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.102.12.1011	Acute Pharyngitis	active	2017-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.102.12.1012	Acute Tonsillitis	active	2017-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.102.12.1017	Competing Conditions for Respiratory Conditions	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.102.12.1022	Upper Respiratory Infection	active	2017-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.102.12.1025	Comorbid Conditions for Respiratory Conditions	active	2022-09
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1021	Amenorrhea	active	2022-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1022	Amenorrhea	active	2023-12
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1025	Bilateral Oophorectomy	active	2021-09
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1026	Unilateral Oophorectomy Left	active	2021-09
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1028	Unilateral Oophorectomy Left	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1029	Unilateral Oophorectomy Left	active	2022-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.103.12.1001	Diabetes	active	2025-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.103.12.1020	Type 1 Diabetes	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1030	Unilateral Oophorectomy Right	active	2021-09
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1031	Unilateral Oophorectomy Right	active	2022-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1032	Unilateral Oophorectomy Right	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1034	Unilateral Oophorectomy, Unspecified Laterality	active	2024-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1035	Unilateral Oophorectomy, Unspecified Laterality	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1036	Eating Disorders	active	2021-09
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1038	Eating Disorders	active	2024-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1039	Eating Disorders	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.104.11.1029	Essential Hypertension	active	2024-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.104.11.1031	Essential Hypertension	active	2017-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.104.12.1011	Essential Hypertension	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1040	Major Transplant	active	2021-09
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1042	Major Transplant	active	2022-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1043	Potentially Harmful Antihistamines for Older Adults	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1046	Evidence of Bilateral Oophorectomy	active	2021-09
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1048	Evidence of Bilateral Oophorectomy	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1049	Potentially Harmful Antiparkinsonian Agents for Older Adults	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.105.11.1010	Mental Health Diagnoses	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.105.11.1012	Mental Health Diagnoses	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.105.11.1017	Major Depression	active	2023-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.105.11.1019	Major Depression	active	2017-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.105.11.1060	Major Depression In Remission	active	2024-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.105.11.1062	Major Depression In Remission	active	2025-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.105.11.1161	Schizophrenia or Psychotic Disorder	active	2022-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.105.11.1162	Schizophrenia or Psychotic Disorder	active	2022-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.105.11.1163	Schizophrenia or Psychotic Disorder	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.105.11.1206	Mental Behavioral and Neurodevelopmental Disorders	active	2024-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.105.11.1207	Mental Behavioral and Neurodevelopmental Disorders	active	2025-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.105.11.1210	Schizophrenia	active	2021-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.105.11.1211	Schizophrenia	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.105.11.1212	Seizure Disorder	active	2024-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.105.11.1213	Seizure Disorder	active	2025-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.105.11.1214	REM	active	2021-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.105.11.1215	REM	active	2021-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.105.11.1216	Benzodiazepine Withdrawal	active	2021-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.105.11.1217	Benzodiazepine Withdrawal	active	2025-04
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.105.11.1218	Alcohol Withdrawal	active	2021-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.105.11.1219	Alcohol Withdrawal	active	2025-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.105.11.1220	General Anxiety	active	2021-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.105.11.1221	General Anxiety	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.105.12.1004	Mental Health Diagnoses	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.105.12.1007	Major Depression	active	2017-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.105.12.1104	Schizophrenia or Psychotic Disorder	active	2024-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.105.12.1203	Mental Behavioral and Neurodevelopmental Disorders	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.105.12.1205	Schizophrenia	active	2021-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.105.12.1206	Seizure Disorder	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.105.12.1207	REM Sleep Behavior Disorder	active	2021-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.105.12.1208	Benzodiazepine Withdrawal	active	2021-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.105.12.1209	Alcohol Withdrawal	active	2021-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.105.12.1210	Generalized Anxiety Disorder	active	2021-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1050	Potentially Harmful Gastrointestinal Antispasmodics for Older Adults	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1051	Dipyridamole Medications	active	2021-09
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1053	Nifedipine Medications	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1054	Potentially Harmful Antidepressants for Older Adults	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1055	Potentially Harmful Barbiturates for Older Adults	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1057	Meprobamate Medications	active	2021-09
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1058	Potentially Harmful Estrogens for Older Adults	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1059	Potentially Harmful Sulfonylureas for Older Adults	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.106.11.1001	Substance Use Disorder	active	2025-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.106.11.1003	Substance Use Disorder	active	2021-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.106.11.1012	Substance Use Disorder Treatment	active	2021-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.106.11.1036	Substance Use Disorder Treatment	active	2021-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.106.12.1001	Substance Use Disorder	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.106.12.1005	Substance Use Disorder Treatment	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1060	Desiccated Thyroid Medications	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1062	Potentially Harmful Skeletal Muscle Relaxants for Older Adults	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1063	Potentially Harmful Pain Medications for Older Adults	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1065	Digoxin Medications	active	2021-09
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1066	Digoxin Medications	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1067	Doxepin Medications	active	2021-09
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1068	Doxepin Medications	active	2021-09
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.108.11.1001	Malignant Neoplasm of Colon	active	2024-11
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.108.11.1003	Malignant Neoplasm of Colon	active	2023-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.108.11.1025	Malignant Neoplasm of Lymphatic and Hematopoietic Tissue	active	2024-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.108.11.1027	Malignant Neoplasm of Lymphatic and Hematopoietic Tissue	active	2022-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.108.11.1044	Pap Test	active	2017-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.108.11.1047	Mammography	active	2024-11
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.108.11.1051	Colonoscopy	active	2023-11
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.108.11.1052	Colonoscopy	active	2017-12
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.108.11.1053	Colonoscopy	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.108.11.1145	sDNA FIT Test	active	2017-12
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.108.12.1001	Malignant Neoplasm of Colon	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.108.12.1009	Malignant Neoplasm of Lymphatic and Hematopoietic Tissue	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.108.12.1017	Pap Test	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.108.12.1018	Mammography	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.108.12.1020	Colonoscopy	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.108.12.1038	CT Colonography	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.108.12.1039	sDNA FIT Test	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.109.11.1024	Kidney Transplant	active	2021-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.109.11.1025	Kidney Transplant	active	2021-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.109.11.1026	Dialysis Services	active	2021-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.109.11.1027	Dialysis Services	active	2021-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.109.11.1028	Dialysis Services	active	2017-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.109.11.1029	ESRD Monthly Outpatient Services	active	2017-08
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.109.11.1052	Kidney Transplant	active	2017-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.109.11.1060	Kidney Transplant Recipient	active	2019-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.109.11.1067	Kidney Transplant	active	2019-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.109.12.1012	Kidney Transplant	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.109.12.1013	Dialysis Services	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.109.12.1014	ESRD Monthly Outpatient Services	active	2017-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.109.12.1029	Kidney Transplant Recipient	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1065	DTaP Vaccine Administered	active	2021-09
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1066	DTaP Vaccine Administered	active	2024-11
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1068	Hepatitis A	active	2019-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1070	Hepatitis A	active	2017-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1078	Measles	active	2021-09
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1080	Measles	active	2017-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1085	Measles, Mumps and Rubella (MMR) Vaccine Administered	active	2017-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1086	Measles, Mumps and Rubella (MMR) Vaccine Administered	active	2023-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1087	Mumps	active	2023-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1089	Mumps	active	2017-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1098	Rubella	active	2021-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.110	Rubella	active	2017-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1104	Varicella Zoster	active	2017-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1105	Varicella Zoster	active	2025-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1106	Varicella Zoster Vaccine (VZV) Administered	active	2017-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1107	Varicella Zoster Vaccine (VZV) Administered	active	2023-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1109	Hepatitis A Vaccine Administered	active	2017-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1110	Hepatitis A Vaccine Administered	active	2024-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1111	Hepatitis B Vaccine Administered	active	2021-09
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1112	Hepatitis B Vaccine Administered	active	2023-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1115	Child Influenza Vaccine Administered	active	2023-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1116	Child Influenza Vaccine Administered	active	2023-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1117	Inactivated Polio Vaccine (IPV) Administered	active	2021-09
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1118	Inactivated Polio Vaccine (IPV) Administered	active	2023-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1119	Pneumococcal Conjugate Vaccine Administered	active	2023-11
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1120	Rotavirus Vaccine (3 dose schedule) Administered	active	2017-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1121	Rotavirus Vaccine (2 dose schedule) Administered	active	2017-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1123	Genital Herpes	active	2024-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1124	Genital Herpes	active	2024-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1128	Lab Tests for Sexually Transmitted Infections	active	2022-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1129	Chlamydia Screening	active	2024-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1133	Pneumococcal Conjugate Vaccine Administered	active	2024-11
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1135	HPV Test	active	2024-11
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1148	Rotavirus Vaccine (2 Dose Schedule) Administered	active	2019-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1149	Rotavirus Vaccine (3 Dose Schedule) Administered	active	2019-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1150	Advanced Illness	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1151	Advanced Illness	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1152	HiB Vaccine (3 dose schedule)	active	2021-12
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1153	HiB Vaccine (3 dose schedule) Administered	active	2021-09
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1154	HiB Vaccine (4 dose schedule)	active	2021-09
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1155	HiB Vaccine (4 dose schedule) Administered	active	2021-09
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1156	HiB Vaccine (3 dose schedule) Administered	active	2024-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1157	HiB Vaccine (4 dose schedule) Administered	active	2024-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1158	Competing Conditions for Respiratory Conditions	active	2024-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1159	Competing Conditions for Respiratory Conditions	active	2023-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1022	DTaP Vaccine Administered	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1024	Hepatitis A	active	2017-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1031	Measles, Mumps and Rubella (MMR) Vaccine Administered	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1032	Mumps	active	2017-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1037	Rubella	active	2017-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1039	Varicella Zoster	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1040	Varicella Zoster Vaccine (VZV) Administered	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1041	Hepatitis A Vaccine Administered	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1042	Hepatitis B Vaccine Administered	active	2022-09
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1044	Child Influenza Vaccine Administered	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1045	Inactivated Polio Vaccine (IPV) Administered	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1046	Pneumococcal Conjugate Vaccine Administered	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1047	Rotavirus Vaccine (3 dose schedule) Administered	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1048	Rotavirus Vaccine (2 dose schedule) Administered	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1049	Genital Herpes	active	2018-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1051	Lab Tests for Sexually Transmitted Infections	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1052	Chlamydia Screening	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1053	Measles	active	2017-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1059	HPV Test	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1082	Advanced Illness	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1083	Hib Vaccine (3 dose schedule)	active	2019-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1084	Hib Vaccine (3 dose schedule) Administered	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1085	Hib Vaccine (4 dose schedule)	active	2019-03